Click on the plus icons to view more information about each section.
R&D and expertise orchestrating a lean operating model
We use in house specialist expertise in Clinical Development, Regulatory and Chemistry, Manufacturing and Controls (CMC) to lead strategy and co-ordinate the outsourcing of key activities.
Proven Innovation
Reformulation expertise optimising delivery of molecules to ensure a rapid and targeted delivery and to minimise side-effects.
Understanding our markets
Our lead asset MED2005 and pipeline are well positioned to benefit from the current market dynamics and demand from patients and consumers for higher quality of life.
Understanding patient needs
In erectile dysfunction, current treatments do not meet the needs of many ED sufferers who want a fast acting, well tolerated treatment that can help restore spontaneity and intimacy back into their relationship.